ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Austin, T. W.
Right arrow Articles by Doctor, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Austin, T. W.
Right arrow Articles by Doctor, A.

Ann Thorac Surg 1977;23:333-336
© 1977 The Society of Thoracic Surgeons


Articles

Cephalothin Prophylaxis and Valve Replacement

T.W. Austin, F.R.C.P.(C)*, J.C. Coles, F.R.C.S.(C), P. McKechnie, B.Sc., W. Sandoval, M.D., A. Doctor, F.R.C.S.(C)

Departments of Cardiovascular Surgery and Medicine, Victoria Hospital, and the School of Medicine, University of Western Ontario, London, Ont, Canada

Accepted for publication August 10, 1976.

* Address reprint requests to Dr. Austin, Department of Medicine, Victoria Hospital, London, Ont, CanadaN6A4G5.

In a study of antibiotic prophylaxis in adults undergoing heart valve replacement, we found that a 2 gm dose of cephalothin given intraoperatively produced adequate antimicrobial activity in the bloodstream throughout the period of cardiopulmonary bypass. A dosage of 1 gm every four hours postoperatively did not lead to significant accumulation of the antibiotic.

With prophylaxis restricted to the intraoperative and early postoperative period, adverse drug reactions and superinfections were not a problem. Further, no cases of prosthetic valvulitis were encountered.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
U. Niederhauser, M. Vogt, P. Vogt, M. Genoni, A. Kunzli, and M. I. Turina
CARDIAC SURGERY IN A HIGH-RISK GROUP OF PATIENTS: IS PROLONGED POSTOPERATIVE ANTIBIOTIC PROPHYLAXIS EFFECTIVE?.
J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 162 - 168.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. G. Sarr, V. L. Gott, and T. R. Townsend
Mediastinal Infection after Cardiac Surgery
Ann. Thorac. Surg., October 1, 1984; 38(4): 415 - 423.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. T. M. Ghoneim, A. P. Tandon, and M. I. Ionescu
Comparative Study of Cefamandole versus Ampicillin plus Cloxacillin: Prophylactic Antibiotics in Cardiac Surgery
Ann. Thorac. Surg., February 1, 1982; 33(2): 152 - 158.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. F. Akl and G. Richardson
Serum Cefazolin Levels during Cardiopulmonary Bypass
Ann. Thorac. Surg., February 1, 1980; 29(2): 109 - 112.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1977 by The Society of Thoracic Surgeons.